186
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Prevalence of Leucopenia and Associated Factors before and after Initiation of ART among HIV-Infected Patients, North East Ethiopia: Cross-Sectional Study

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 269-276 | Published online: 10 May 2021

References

  • Shen Y, Wang J, Wang Z, et al. A cross-sectional study of leukopenia and thrombocytopenia among Chinese adults with newly diagnosed HIV/AIDS. Biosci Trends. 2015;9(2):91–96. doi:10.5582/bst.2015.01024
  • Gebreweld A, Fiseha T, Girma N, Haileslasie H, Gebretsadik D. Prevalence of cytopenia and its associated factors among HIV infected adults on highly active antiretroviral therapy at Mehal Meda Hospital, North Shewa Zone, Ethiopia. PLoS One. 2020;15(9):e0239215. doi:10.1371/journal.pone.0239215
  • Fekene TE, Juhar LH, Mengesha CH, Worku DK. Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study. BMC Hematol. 2018;18:8.
  • Afari S, Blay E. Prevalence of haematological and serum biochemical abnormalities in hiv infected patients in Ghana, before and after antiretroviral therapy. Int J Virol AIDS. 2018;5(1):039.
  • Tamir Z, Seid A, Haileslassie H. Magnitude and associated factors of cytopenias among antiretroviral therapy naïve Human Immunodeficiency Virus infected adults in Dessie, Northeast Ethiopia. PLoS One. 2019;14(2):e0211708.
  • Choi SY, Kim I, Kim NJ, et al. Hematological manifestations of human immunodeficiency virus infection and the effect of highly active anti-retroviral therapy on cytopenia. Korean J Hematol. 2011;46(4):253–257. doi:10.5045/kjh.2011.46.4.253
  • Akinbami A, Oshinaike O, Adeyemo T, et al. Hematologic abnormalities in treatment-naive HIV patients. Infect Dis Res Treat. 2010;3(IDRT):S6033.
  • Addis Z, Yitayew G, Tachebele B. Prevalence of some hematological abnormalities among HIV positive patients on their first visit to a tertiary health institution in ethiopia; a cross sectional study. Int Blood Res Rev. 2014;2:270–278. doi:10.9734/IBRR/2014/11137
  • Dikshit B, Wanchu A, Sachdeva RK, Sharma A, Das R. Profile of hematological abnormalities of Indian HIV infected individuals. BMC Hematol. 2009;9(1):1–6. doi:10.1186/1471-2326-9-5
  • Levine AM, Karim R, Mack W, et al. Neutropenia in human immunodeficiency virus infection: data from the women’s interagency HIV study. Arch Intern Med. 2006;166(4):405–410. doi:10.1001/archinte.166.4.405
  • Amegor O, Bigila D, Oyesola O, Oyesola T, Buseni S. Hematological changes in HIV patients placed on anti retroviral therapy in Markurdi, Benue State of Nigeria. Asian J Epidemiol. 2009;2(4):97–103. doi:10.3923/aje.2009.97.103
  • Zama II, Amina A, Abdulrahaman Y, Yeldu MH. Some haematological profile of HIV/AIDS patients on Highly Active Antiretroviral Therapy(HAART) in Usamanu Danfodiyo University Teaching Hospital Sokoto, North-Western Nigeria.J Sci Technol. 2014;2(1):27–32.
  • Ako SE, Njunda LA, Akum EA, et al. Immuno-hematological Profile Trends of HIV/AIDs Patients on HAART in the South west region of cameroon: retrospective medical report review for possible stratified follow-up pattern in low income settings. Am J Microbiol Res. 2018;6(2):47–56. doi:10.12691/ajmr-6-2-3
  • Servais J, Nkoghe D, Schmit J-C, et al. HIV-associated hematologic disorders are correlated with plasma viral load and improve under highly active antiretroviral therapy. J Acquired Immune Deficiency Syndromes. 2001;28(3):221–225. doi:10.1097/00042560-200111010-00003
  • Odunukwe N, Idigbe O, Kanki P, et al. Haematological and biochemical response to treatment of HIV-1 infection with a combination of nevirapine+ stavudine+ lamivudine in Lagos Nigeria. Turkish J Haematol. 2005;22(3):125–131.
  • Enawgaw B, Alem M, Addis Z, Melku M. Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative cross-sectional study. BMC Hematol. 2014;14(1):1–7.
  • Wanjari A, Acharya S, Singh AP, Rathi C. A study of hematological profile in HIV/AIDS. AIDS. 2013;8:9.
  • Idowu C, Oke O, Afolayan D, Olaniran O, Akinloye O, Awodumila O. Effect of HAART on some haematological parameters, correlations between total lymphocyte and CD4 counts of HIV clients attending ssh, ikole-ekiti. Int J Biol Med Res. 2013;4(3):3265–3270.
  • Ijeoma OL, Ifeoma UE, Emmanuel O, Ifeanyi AU, Andrew A. Comparative study of Cd8+ T-Cell count and leukopoietin levels in human immunodeficiency virus infection in Umuahia, Nigeria. IOSR J Dental Med Sci. 2014;13:102–110. doi:10.9790/0853-1392102110
  • Katemba C, Muzoora C, Muwanguzi E, Mwambi B, Atuhairwe C, Taremwa IM. Hematological abnormalities in HIV-antiretroviral therapy naïve clients as seen at an immune suppression syndrome clinic at Mbarara Regional Referral Hospital, southwestern Uganda. J Blood Med. 2018;9:105. doi:10.2147/JBM.S157148
  • Tamir Z, Seid A, Haileslassie H. Magnitude and associated factors of cytopenias among antiretroviral therapy naive Human Immunodeficiency Virus infected adults in Dessie, Northeast Ethiopia. PLoS One. 2019;14(2):e0211708. doi:10.1371/journal.pone.0211708
  • Forna F, Moore D, Mermin J, et al. Hematologic changes associated with Zidovudine following single-drug substitution from stavudine in a home-based AIDS care program in rural Uganda. J Int Assoc Physicians AIDS Care. 2009;8(2):128–138. doi:10.1177/1545109709333081
  • Fekene TE, Juhar LH, Mengesha CH, Worku DK. Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study. BMC Hematol. 2018;18(1):1–11. doi:10.1186/s12878-018-0102-7